# Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material

> **NCT00558142** · PHASE4 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 107 (actual)

## Conditions studied

- Radiocontrast-induced Nephropathy

## Interventions

- **DRUG:** Acetylcysteine
- **DRUG:** Visipaque 320
- **DRUG:** Visipaque 320

## Key facts

- **NCT ID:** NCT00558142
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00558142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00558142, "Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00558142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*